Reverse-phase protein microarrays, as an antibody-based proteomic technology, have also been applied to analyze EV cargo and were used to identify a series of potential biomarkers for EV-based PCa diagnosis, such as PD-1 and survivin (Signore et al., 2021). The gene discussed is BIRC5; the disease is posterior cortical atrophy.